Notice of Clarification of Eligibility for "Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp- Clinical Trial Not Allowed)"

Notice Number: NOT-AR-20-014

Key Dates
Release Date: January 27, 2020

Related Announcements
PA-18-914

Issued by
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

The purpose of this Notice is to clarify the eligibility information for PA-18-914, "Supplements to Advance Research (STAR) from Projects to Programs."

The following section of PA-18-914 has been revised:

Part 1. Overview Information

Funding Opportunity Purpose

Currently reads:

The eligible investigators may have a maximum of two active R01-equivalent NIH grants at the time of STAR application (i.e., can have the first R01 renewal and one other R01-equivalent).

Modified to read:

Eligible investigators for the STAR award have never held more than two R01-equivalent grants (https://grants.nih.gov/grants/glossary.htm#R) including the renewed R01 that was funded by NIAMS with ESI status.

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

Currently reads:

The eligible investigators may have a maximum of two active R01-equivalent NIH grants at the time of STAR application (i.e., can have the first R01 renewal and one other R01-equivalent).

Modified to read:

Eligible investigators for the STAR award have never held more than two R01-equivalent grants including the renewed R01 that was funded by NIAMS with ESI status.

Section III. Eligibility Information

Additional Eligibility Requirements

Currently reads:

The eligible investigators may have a maximum of two active R01-equivalent NIH grants at the time of STAR application (i.e., can have the first R01 renewal and one other R01-equivalent); however the NIAMS-funded renewal must represent the primary focus of interest of the PD/PI’s laboratory. Investigators may receive only one supplement award under the NIAMS STAR program.

Modified to read:

Eligible investigators for the STAR award have never held more than two R01-equivalent grants including the renewed R01 that was funded by NIAMS with ESI status; however the NIAMS-funded renewal must represent the primary focus of interest of the PD/PI’s laboratory. Investigators may receive only one supplement award under the NIAMS STAR program.

Inquiries

Please direct all inquiries to:

Heiyoung Park, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-3507
Email: niamsstar@mail.nih.gov